Document Detail


Controlled clinical trial comparing flurbiprofen and phenylbutazone in patients with rheumatoid arthritis.
MedLine Citation:
PMID:  334476     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Preliminary results in 12 patients with rheumatoid arthritis are presented from an on-going double-blind, between patient comparison of flurbiprofen and phenylbutazone. Patients received either 300 mg flurbiprofen daily or 400 mg phenylbutazone daily over a 2-week treatment period. Two patients treated with phenylbutazone developed a rash, and treatment was discontinued in 1 of them after Day 2.
Authors:
P A Franco; S Ferri; O Di Mummo
Related Documents :
15832106 - Mizoribine-induced rhabdomyolysis in a rheumatoid arthritis patient receiving bezafibra...
14637276 - Antioxidant status in rheumatoid arthritis and role of antioxidant therapy.
9137326 - Incidence of ocular complications in rheumatoid arthritis and the relation of keratocon...
20631196 - Febuxostat for gout.
7239846 - The relationship between visual sensitivity and rhodopsin density in retinitis pigmentosa.
10864116 - Isolated sphenoid sinus diseases: report of 39 cases.
Publication Detail:
Type:  Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  Current medical research and opinion     Volume:  5     ISSN:  0300-7995     ISO Abbreviation:  Curr Med Res Opin     Publication Date:  1977  
Date Detail:
Created Date:  1977-12-29     Completed Date:  1977-12-29     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0351014     Medline TA:  Curr Med Res Opin     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  74-6     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Arthritis, Rheumatoid / drug therapy*
Clinical Trials as Topic
Double-Blind Method
Flurbiprofen / therapeutic use*
Humans
Phenylbutazone / therapeutic use*
Propionates / therapeutic use*
Chemical
Reg. No./Substance:
0/Propionates; 50-33-9/Phenylbutazone; 5104-49-4/Flurbiprofen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A comparative study of the long-term efficacy of flurbiprofen and indomethacin in the treatment of r...
Next Document:  Flurbiprofen and indomethacin in the treatment of rheumatoid arthritis: a double-blind crossover stu...